Valuation : Ha Tay Pharmaceutical

Market Cap 5,054B 192M 167M 157M 142M 268M 18.33B 268M 1.85B 718M 9.4B 728M 713M 30.3B P/E 2024
109x
P/E 2025 109x
Enterprise Value 5,153B 196M 170M 160M 144M 273M 18.68B 273M 1.89B 732M 9.58B 742M 727M 30.89B EV / Sales 2024
3.89x
EV / Sales 2025 2.68x
Free-Float
25%
Yield 2024 *
-
Yield 2025 -
1 day+0.18%
1 week-1.41%
Current month-1.41%
1 month-6.22%
3 months-15.07%
6 months-19.36%
Current year-20.29%
1 week 54,800
Extreme 54800
56,000
1 month 54,400
Extreme 54400
61,000
Current year 54,400
Extreme 54400
75,800
1 year 54,400
Extreme 54400
86,800
3 years 17,090.91
Extreme 17090.90909
100,818.18
5 years 11,980.52
Extreme 11980.519478
100,818.18
10 years 4,801.26
Extreme 4801.259345
100,818.18
Manager TitleAgeSince
Chief Executive Officer 53 31/03/2016
Corporate Officer/Principal - 29/02/2016
Corporate Officer/Principal 49 03/02/2015
Director TitleAgeSince
Chairman 75 31/12/2015
Director/Board Member 53 -
Director/Board Member 62 31/05/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%-1.41%-29.12%+165.71% 194M
-0.88%-2.15%+58.05%+105.91% 1,024B
-1.15%+2.68%+54.25%+71.29% 663B
-1.44%+0.38%+20.65%+75.54% 453B
+0.14%-0.47%+30.20%+40.61% 352B
-1.33%+4.72%+24.62%+47.60% 304B
-1.15%+0.30%-0.69%+11.83% 252B
-1.55%+1.11%+54.15%+72.13% 236B
-0.88%+1.15%-14.60%-54.84% 206B
-0.15%+3.65%+31.24%+100.90% 187B
Average -0.82%+0.74%+22.87%+63.67% 367.86B
Weighted average by Cap. -0.96%+0.55%+37.63%+67.01%

Financials

2024 2025
Net sales 2,086B 79.28M 68.85M 64.68M 58.42M 111M 7.57B 111M 766M 296M 3.88B 300M 294M 12.51B 2,402B 91.28M 79.27M 74.46M 67.26M 127M 8.71B 127M 882M 341M 4.47B 346M 339M 14.4B
Net income 71.77B 2.73M 2.37M 2.22M 2.01M 3.8M 260M 3.8M 26.34M 10.19M 133M 10.34M 10.12M 430M 53.66B 2.04M 1.77M 1.66M 1.5M 2.84M 195M 2.84M 19.69M 7.62M 99.75M 7.73M 7.57M 322M
Net Debt 290B 11.02M 9.57M 8.99M 8.12M 15.37M 1.05B 15.37M 106M 41.17M 539M 41.75M 40.88M 1.74B 98.73B 3.75M 3.26M 3.06M 2.76M 5.23M 358M 5.23M 36.23M 14.02M 184M 14.22M 13.92M 592M
Logo Ha Tay Pharmaceutical
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Employees
586
Date Price Change Volume
04/09/26 ₫55,800.00 +0.18% 7,707
03/09/26 ₫55,700.00 -1.59% 510